These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

105 related items for PubMed ID: 7507238

  • 1. Nuclear casein kinase 2 (CK-2) activity in human normal, benign hyperplastic, and cancerous prostate.
    Yenice S, Davis AT, Goueli SA, Akdas A, Limas C, Ahmed K.
    Prostate; 1994; 24(1):11-6. PubMed ID: 7507238
    [Abstract] [Full Text] [Related]

  • 2. Significance of the casein kinase system in cell growth and proliferation with emphasis on studies of the androgenic regulation of the prostate.
    Ahmed K.
    Cell Mol Biol Res; 1994; 40(1):1-11. PubMed ID: 7528596
    [Abstract] [Full Text] [Related]

  • 3. Chromatin-associated protein kinases in human normal and benign hyperplastic prostate.
    Rayan A, Goueli SA, Lange P, Ahmed K.
    Cancer Res; 1985 May; 45(5):2277-82. PubMed ID: 2580618
    [Abstract] [Full Text] [Related]

  • 4. Association of casein kinase 2 with nuclear chromatin in relation to androgenic regulation of rat prostate.
    Ahmed K, Yenice S, Davis A, Goueli SA.
    Proc Natl Acad Sci U S A; 1993 May 15; 90(10):4426-30. PubMed ID: 8506283
    [Abstract] [Full Text] [Related]

  • 5. Tyrosine protein kinase activity of human hyperplastic prostate and carcinoma cell lines PC3 and DU145.
    Durocher Y, Chapdelaine A, Chevalier S.
    Cancer Res; 1989 Sep 01; 49(17):4818-23. PubMed ID: 2474374
    [Abstract] [Full Text] [Related]

  • 6. The prognostic significance of p34cdc2 and cyclin D1 protein expression in prostate adenocarcinoma.
    Kallakury BV, Sheehan CE, Ambros RA, Fisher HA, Kaufman RP, Ross JS.
    Cancer; 1997 Aug 15; 80(4):753-63. PubMed ID: 9264360
    [Abstract] [Full Text] [Related]

  • 7. Alpha-methylacyl-CoA racemase (P504S) expression in evolving carcinomas within benign prostatic hyperplasia and in cancers of the transition zone.
    Leav I, McNeal JE, Ho SM, Jiang Z.
    Hum Pathol; 2003 Mar 15; 34(3):228-33. PubMed ID: 12673556
    [Abstract] [Full Text] [Related]

  • 8. Regulation of proliferation/apoptosis equilibrium by mitogen-activated protein kinases in normal, hyperplastic, and carcinomatous human prostate.
    Royuela M, Arenas MI, Bethencourt FR, Sánchez-Chapado M, Fraile B, Paniagua R.
    Hum Pathol; 2002 Mar 15; 33(3):299-306. PubMed ID: 11979370
    [Abstract] [Full Text] [Related]

  • 9. Expression of adrenomedullin and peptide amidation activity in human prostate cancer and in human prostate cancer cell lines.
    Rocchi P, Boudouresque F, Zamora AJ, Muracciole X, Lechevallier E, Martin PM, Ouafik L.
    Cancer Res; 2001 Feb 01; 61(3):1196-206. PubMed ID: 11221851
    [Abstract] [Full Text] [Related]

  • 10. Hepsin immunohistochemical expression in prostate cancer in relation to Gleason's grade and serum prostate specific antigen.
    Goel MM, Agrawal D, Natu SM, Goel A.
    Indian J Pathol Microbiol; 2011 Feb 01; 54(3):476-81. PubMed ID: 21934206
    [Abstract] [Full Text] [Related]

  • 11. Androgenic regulation of protein kinase CK1 in the prostatic cell.
    Ahmed K, Davis AT, Canbulat EC, Marin O, Pinna LA.
    Cell Mol Biol Res; 1995 Feb 01; 41(5):421-4. PubMed ID: 8867789
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Epigenetic events, remodelling enzymes and their relationship to chromatin organization in prostatic intraepithelial neoplasia and prostatic adenocarcinoma.
    Mohamed MA, Greif PA, Diamond J, Sharaf O, Maxwell P, Montironi R, Young RA, Hamilton PW.
    BJU Int; 2007 Apr 01; 99(4):908-15. PubMed ID: 17378849
    [Abstract] [Full Text] [Related]

  • 15. Adenosine deaminase specific activity in normal, benign hypertrophied and neoplastic human prostate tissue.
    Tritsch GL, Murphy GP.
    Eur Urol; 1980 Apr 01; 6(4):229-31. PubMed ID: 6156073
    [Abstract] [Full Text] [Related]

  • 16. Regulation of PDE5 expression in normal prostate, benign prostatic hyperplasia, and adenocarcinoma.
    Bisegna C, Gravina GL, Pierconti F, Martini M, Larocca L, Rossi P, Grimaldi P, Dolci S, Di Stasi S, Jannini EA.
    Andrology; 2020 Mar 01; 8(2):427-433. PubMed ID: 31433119
    [Abstract] [Full Text] [Related]

  • 17. Localization of angiotensin-converting enzyme in the human prostate: pathological expression in benign prostatic hyperplasia.
    Nassis L, Frauman AG, Ohishi M, Zhuo J, Casley DJ, Johnston CI, Fabiani ME.
    J Pathol; 2001 Dec 01; 195(5):571-9. PubMed ID: 11745693
    [Abstract] [Full Text] [Related]

  • 18. Differences in the leucine aminopeptidase activity in extracts from human prostatic carcinoma and benign prostatic hyperplasia.
    Rackley RR, Yang B, Pretlow TG, Abdul-Karim FW, Lewis TJ, McNamara N, Delmoro CM, Bradley EL, Kursh E, Resnick MI.
    Cancer; 1991 Aug 01; 68(3):587-93. PubMed ID: 1712242
    [Abstract] [Full Text] [Related]

  • 19. Expression of the non-gastric H+/K+ ATPase ATP12A in normal and pathological human prostate tissue.
    Streif D, Iglseder E, Hauser-Kronberger C, Fink KG, Jakab M, Ritter M.
    Cell Physiol Biochem; 2011 Aug 01; 28(6):1287-94. PubMed ID: 22179016
    [Abstract] [Full Text] [Related]

  • 20. Creatine phosphokinase isoenzymes in human prostatic tissues: a comparison between benign hyperplasia and adenocarcinoma.
    Truong T, Carmel M, Elhilali M, Cloutier D, Lehoux JG.
    Prostate; 1985 Aug 01; 7(2):143-9. PubMed ID: 2413430
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.